These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24565016)

  • 21. Effect of PICALM rs3851179 polymorphism on the default mode network function in mild cognitive impairment.
    Sun DM; Chen HF; Zuo QL; Su F; Bai F; Liu CF
    Behav Brain Res; 2017 Jul; 331():225-232. PubMed ID: 28549650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.
    Krell-Roesch J; Vemuri P; Pink A; Roberts RO; Stokin GB; Mielke MM; Christianson TJ; Knopman DS; Petersen RC; Kremers WK; Geda YE
    JAMA Neurol; 2017 Mar; 74(3):332-338. PubMed ID: 28135351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotype.
    Kester MI; Verwey NA; van Elk EJ; Blankenstein MA; Scheltens P; van der Flier WM
    Neurobiol Aging; 2011 Aug; 32(8):1372-8. PubMed ID: 19748159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment.
    Laczó J; Andel R; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Lerch O; Gazova I; Moffat SD; Hort J
    Neurobiol Aging; 2015 Jun; 36(6):2024-33. PubMed ID: 25862420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients.
    Lanni C; Garbin G; Lisa A; Biundo F; Ranzenigo A; Sinforiani E; Cuzzoni G; Govoni S; Ranzani GN; Racchi M
    J Alzheimers Dis; 2012; 32(4):919-26. PubMed ID: 22890094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between DCHS2 gene and mild cognitive impairment and Alzheimer's disease in an elderly Brazilian sample.
    Vieira RN; Ávila R; de Paula JJ; Cintra MT; de Souza RP; Nicolato R; Malloy-Diniz L; de Miranda DM; de Moraes EN; de Marco LA; Romano-Silva MA; Bicalho MA
    Int J Geriatr Psychiatry; 2016 Dec; 31(12):1337-1344. PubMed ID: 26876984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases.
    Tisato V; Zuliani G; Vigliano M; Longo G; Franchini E; Secchiero P; Zauli G; Paraboschi EM; Vikram Singh A; Serino ML; Ortolani B; Zurlo A; Bosi C; Greco A; Seripa D; Asselta R; Gemmati D
    PLoS One; 2018; 13(3):e0193867. PubMed ID: 29518107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hierarchical Bayesian cognitive processing models to analyze clinical trial data.
    Shankle WR; Hara J; Mangrola T; Hendrix S; Alva G; Lee MD
    Alzheimers Dement; 2013 Jul; 9(4):422-8. PubMed ID: 23123230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment.
    Chico L; Simoncini C; Lo Gerfo A; Rocchi A; Petrozzi L; Carlesi C; Volpi L; Tognoni G; Siciliano G; Bonuccelli U
    Free Radic Res; 2013 Aug; 47(8):569-76. PubMed ID: 23668794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conversion from MCI to AD in patients with the APOE ε4 genotype: Prediction by plasma HCY and serum BDNF.
    Zheng L; Kong X; Cui Y; Wei Y; Zhang J; Wei W
    Neurosci Lett; 2016 Jul; 626():19-24. PubMed ID: 27180036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of pharmacogenetic factors on Alzheimer's disease therapeutics.
    Cacabelos R
    Neurodegener Dis; 2008; 5(3-4):176-8. PubMed ID: 18322383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
    López ME; Turrero A; Cuesta P; López-Sanz D; Bruña R; Marcos A; Gil P; Yus M; Barabash A; Cabranes JA; Maestú F; Fernández A
    J Alzheimers Dis; 2016 Mar; 52(1):133-43. PubMed ID: 27060953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
    Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
    J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple genetic imaging study of the association between cholesterol metabolism and brain functional alterations in individuals with risk factors for Alzheimer's disease.
    Bai F; Yuan Y; Shi Y; Zhang Z
    Oncotarget; 2016 Mar; 7(13):15315-28. PubMed ID: 26985771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer's disease.
    Morgen K; Frölich L; Tost H; Plichta MM; Kölsch H; Rakebrandt F; Rienhoff O; Jessen F; Peters O; Jahn H; Luckhaus C; Hüll M; Gertz HJ; Schröder J; Hampel H; Teipel SJ; Pantel J; Heuser I; Wiltfang J; Rüther E; Kornhuber J; Maier W; Meyer-Lindenberg A
    J Alzheimers Dis; 2013; 37(2):389-401. PubMed ID: 23948881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
    Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
    Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology.
    Ramakers IH; Visser PJ; Aalten P; Bekers O; Sleegers K; van Broeckhoven CL; Jolles J; Verhey FR
    Dement Geriatr Cogn Disord; 2008; 26(2):101-8. PubMed ID: 18617739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.